512036 — Skybiotech Healthcare Income Statement
0.000.00%
Last trade - 00:00- IN₹364.33m
- IN₹454.50m
- IN₹70.52m
Annual income statement for Skybiotech Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | — | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 70.5 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 34.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.678 | 0.605 | 0.615 | 1.27 | 98.5 |
| Operating Profit | -0.678 | -0.605 | -0.615 | -1.27 | -28 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.482 | -0.378 | -0.074 | 18.7 | -24.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.481 | -0.378 | -0.072 | 15.4 | -23.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.481 | -0.378 | -0.072 | 15.4 | -23.7 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.481 | -0.378 | -0.072 | 15.4 | -23.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.463 | -0.364 | -0.038 | 8.02 | -12.4 |